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~ Factors AssOciated With Severe Incomplete Stent 
Expansion; IVUS Analysis of 414 Patients 
Enrolled In the AVID Study 
S, Mukal, R,J, RaseD, PS, Tetrstoln, H, G(lutt, P,J, FIIzgorald, For the AVID 
#lvestlg~ter~: Stanford University, Stanford, CA; Scripps CliltlC, La Jells, CA, 
USA 
Several prior studies have correlated cleat under.expanelon wlCh adverse 
long,term clinical outcome, To evaluate parameters related to s0vero stoat 
under.expansion (defined as minimum slant area [MSA] le~a than 5 mm~), 
motorized pullback IVU$ Images were analy~'od from 461 Palmaz.~¢hatz 
slants deployed in 389 native vessels (165 LAD, t03 RCA, ~9 LCX, 2 LM) and 
72 t;aphenout~ vain graff~, for 4t4 patients enrolled In the AVID (Anglography 
Ve, Intravas(;ular ultrasound Directed coronary slant placement) study, fVUS 
Images were obtained offer an optimal angt¢~grapl~lc resell (.~. 10% reetdeal 
ateneels by visual estimate), Quantitative analysis of ultrasound imagos was 
pedotmed at the proximal and distal reference sites as well e~ at 3.5 mm 
Intervals throughout the slanted region, 
Results: Among 461 cases, 69 (15,0%) had severe under.o~panston; 
MSA < ~ mm ~, In a multivariate analysis, tour p~ramoter~ ohowed a role. 
tlonshlp with a ~maU MSA (. 5 mm =): 1) ~n'~nll distal vessel area (p .  0,001)', 
2) large dlst~l plaque area, defined aa vessel a~'oa, h~mon area, (p .~ 0,001); 
3) ~mall vessel area at prox rot (p ,  0,01); and 4) Incidence of slgnltie~lnt 
inflow or outflow dlsoaso, (% plaque area ..G0% at rot site; p .  0,01 ), 
Concl~l,'~lon: ~mnil vessel si~e at beth th0 proximal and distal reference 
segments, largo plaque area at the distal re,stance, and oc~urrrmeo f 
significant Inflow er outflow disease are a~S0~;let~d with small minimum stoat 
~re~ d~splto an adequate angtographlc result, 
Quantitative Anglogrephy P{,rameters Fell tO 
. . . . . . .  Accurately PredlctStent Expansion 
J, Betas, J, Ellzaga, E Garcfa, J, BarmaiD, M, Fe~ldoul, J $orirmo, 
M, Abeytua, R, Lopoz.Palop, F, Samago, G, Mlgllaro, J,L, Delete, 
Can:llologla, Hospital Gmgorto Mara~n, MadrirJ, ~p~in 
IVUS Is Increasingly used to assess adequate slant deployment, However, it 
Is not universally available an It increases the cost of the procedure. Although 
eyeball evaluation oi post.slant nngtogram has been unable 1o predict ade- 
qu=e steal expansion it is unclear whether carelulty pedormed QCA could 
accurately predict it, Thgrelore, 81 slanted lesions were studied, Slants (30 
PS, 27 Wiktor, 13 Wallstant, 8 Mulflllnk, 3 Others, all ~ 25 ram) were implanted 
et 15 ± 1,8 atm (all -12 aim), with a 1,16 :t 0.17 Balloon/Artery ratio. QCA 
(automated edge detection, CM$) and IVUS analyses were performed in 
blinded fashion, Angio Re1 Diem was 3.;~ :J0.6 ram, %DS pro 65 ~ 15, %DS 
post 11 ~ 11 and lesion length 9,4 J 5.2 ram. IVU$ mean slant expansion 
(minimal CSA within slant/average proximal and distal Rat CSA) was 80 
~. 17%, Optimal expansion, defined as -80%, was achieved in 37 stoats 
(46%), The predictive value of baseline Angio characteristics (Rat Diem. pra 
and post MLD and %DS, lesion length, plaque area, de novo/resten~sis, 
vessel involved) and procedural data (balloon size, B/A ratio, maximal bal. 
loon pressure, steal type) were assessed using logistic regression rmalysis, 
AngtographiC predictors of optimal slant expansion were (untvartate analysis) 
shorter lesions (p .~ 0,001), smaller Ref Diem (p < 0.01), smaller plaque areas 
(p == 0,001), al'~d smaller %DS post (p = 0.02). By multivariate analysis only 
lesion length Showed independent value (OR 0,011 g5%CI 0,0004-0.17), 
although the overall diagnostic accuracy el the model was only 65%, 
Conclusions: Even in this cohort of relatively short lesions longer atenoses 
were associated with smaller expansion suggesting a possible mechanism 
for their ,sported higher restenosis rates, Although careful attention to anglo 
lesion characteristiCS should be emphasized, established OCA parameters 
cannot accurately predict slant expansion, 
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~ Overexpression of Endothelial NO-Synthase 
(eNOS) Causes Mark¢:l Endothelial Cell (2C) 
Differentiation In a Co-culture Model of 
Angiogenesls 
S. ~abae~. K, Teichert-Kuliszewska, J,C, Monge, A,I.M. Campbell, 
D.J. Stewart, Terrence Donnelly Heart Centre, St. Michael's Hospital, 
University of Toronto. Ontario, Canada 
Background: We have previously shown that NO contributes to angi0gonesis 
by terminating the proliferative actions of rmgiogentc growth factors and 
inlUating a genetic progr~tm of EC differentiation, 
Methods: To explore the potential of oNeS gone transfer in anglogenesis, 
oalf pulmonary endothallum coils worn grown on a fibrin matrix ¢ontalnlrtg wild 
type twit) SMC or SMC stably transfocted with eNOS or v,~scular endothelial 
growth feeler (V~GF). EC dlffarentlatlon was quantiflod u,;ing the r~tlO of 
EC "tube" length over EC area (dlfferentlatlon I dex, DI), NO levels wore 
measured by Grless reagent, 
Results: Co.ol,=lturo of ECS with wlt SMCa had no effect on EC differenti. 
allen (DI ~ 2,a ± 3,4) compared with EC alot~e (DI ~, 1,6 .~ 2,B, NS), SMCs 
tranelt~cted with eNOS produt;ed a 3 fold higher levels of NO compared to 
EC alone, In co.collar0 with EC, geNeS tmnsfocted SMC ifldooed profound 
dlfforontl~tl0n, resulting in tho formation of extensive ¢aplllatyqike truct~lroS 
within 40 h (DI ,,, 23,1 :~ 3,9, p .~ 0,00t), which was not dilforent from the 
resp0nee to VEGF overexpre/;sion (DI ~ 15,t 1: 3,5), The inhibition of on. 
degonoua NO pr0duellon using L.NAME (10 raM) algnlfieanlty reduced EC 
differentiation i  1he Do.culture model (DI ~, ?.~ ± 7,2 ~ 0,1, p ,~ 0,001 W,, 
oNO~), 
Conclu#ion: These data confirm the impatient role of NO in EG differen. 
tlation in wire, and suggest that the overexpro~ion of eNO~ may provide 
novel approach for induction of angiogonesis in viva. 
A.,Iote.eln, Modut J. c.,po.,, m,NA. 
......... IExpremslon In Aortic ~moOth Muscle Cells In vi t ro  
end irl v im 
WMM. van do Greet ~ , G, Casloldi ~, CR,T, di Gio ia  't , F, Clementi  , 
M,.R, Camellittl ~ , P. Camisasca ~, F, Pioru;tzi ~, G P~a~:acclli;'., G. Spedi ~ ,
A, Stalls ~, ~ lnst#tate l Cardiology; C~tho/ic Unwersi~ Ron'~. Italy; 
Department Of ClialcaI Physiology, Milan University,, Milan, Italy 
Background: Angtotensln II (All) action on vascular smooth muscle (VSM), 
is not limited to immediate vasoconstriction but includes long term effects 
such as hypertrophy and hyperplasia, This implies a complex pattern el gone 
modulation WhiCh remains largely unknown, 
Methods: We have used the differential display method to screen rat 
aortic VSM cells cultured with or without All treatment, We cloned several 
difforentlally expressed genes, one el which is calponin, a 34 kD protein which 
regulates VSM DOll contraction by tnhibiti0n of myosin.activated MgATPase. 
To investigate whether All has a similar effect on calponin in wvo, male 
Spraguo.Dawley rats were treated for 6 days with a continuous administration 
O1 All at 200 ng/kg/min (n = 6) or vehic;le (n = 6) through osmotic minipumps. 
ResultS: Calponin mRNA was strongly induced by All (2 ,, 10 ~' M) 
treatment in confluent quiescent VSM cells, The signal peaked at 3 h. b=.=t 
was still above baseline values after 24 h, The All effect was dose-related. 
with an induction still evident at 5 ~ 10 9 M All, and was totally abolished by 
the ATl-receptor antagonist lesartan at a concentration ol 1 ', 10 6 M The All 
effect does not require active protein synthesis as cyctoh~ximide treatment 
caused a striking supennductton ol catponin mRNA. In v=vo we observed in 
AU treated rats a significant increase of calponin mRNA express(on in aorta 
(1.10 • 0.58 vs. OA5 ± 0.29, arbitrary units, p = 0,012). 
COnclusion: Our data demonstrate that All modulates calponin expression 
in aortic VSM cells both in vitro and in viva, This could have important 
implications tar the modulation el VSM cell phenotype and function in various 
diseases characterized by activation el the renin-angiotensin system. 
Mlcroveasel Development Following Therapeutic 
Anglogenesls With VaScular Endothelial Growth 
Factor (VEGF) in e Rat MOdel of Htndllmb 
Isehemia 
S. Takeshita, T. Isshiki. Y. Miyazawa, K. Eto, M. Ochiai, E. Tanaka, H, Mort, 
T, Sate. Department of Medicine. Teikyo Uaiversity Hospital Tokyo, Japan 
Background: Recent investigations indicate the feasibility of using vascular 
endothelial growth lector (VEGF), an endothelial cell specific mitogen, to 
further augment he development ot collateral arteries in the lower extremity, 
In the current study, we investigated the collateral microvessel development 
following therapeutic angiogenesis with VEGF using a previously validated 
microangiography s stem that employs monochromatic synchrotron radiation 
(SR) and a high definition video camera with a spatial resolution of 30 l~m, 
Methods: Ischemia was induced in one limb of rats by excision of a 
femoral a-tory (n = 22). Gone transfer (GT) of VEGF or LacZ (control) was 
then performed by directly injecting the relevant plasmid (400 ~g) into the 
limb muscles, At day 30 post-GT, development o! collateral mtcrovessels and 
their vasomotor esponses were assessed by using SR microangiography, 
Results: SR microangiography clearly demonstrated fine networks of col- 
lateral microvessels (<100 i~m in diameter) in both groups, GT of VEGF 
produced morphologically similar, but significantly more e×tensive, micrevas- 
culer networks as compared with the control animals (angiographic score: 
0,88 :~ 0,08 vs 0,54 ± 0.05. p<0.0t), Administration of papaverine and/or 
JACC Fchnmr.~ lqtPX ABS'I'RA(~.~ + Po,,tcr III,~A 
acetylcholine induced only modost dilation O| collateral microv~ssels in c~n- 
tml animals, while it caused profound ilation in VEGF.tteafed ammals Such 
improve~ rospons~s of COllateral m~crevessets in tho VEGF.treated animals 
wean mote ovl(lont i(i vessels with a lir~ar appoaran¢o th~n m those with an 
undulating apl~aranc~, 
Conclusions: GT of VEGF successfully augmented tho collateral devel. 
opro~nf and improved the vasomotor ~l:~OnSes at the m~crovascutar levol, 
Those results may help to provld~ n~w insights re~rd=ng the trilateral mi, 
crociroulahen and theral.~ti¢ tmglo~r~sls, 
• Hynlummm,lndu©e¢l Modlfleallon of Ht~m~in 
Aottlc Smoolh Mus(=le Cell Expmtl~Ion of 
Flbrtnol~l© System ProloIns 8nd IIS ImWleatlons 
for VHoulOl~thy In Olal~tlcl; 
K. Mamfsuk,~, J.. W~k+Mifch~l l ,  1". Sakamoto, B.E SObol, S+ FUlii. 
Uaive~@ of ti~rmont Coll~.}e Of Med~cJn(~, l~vrlin~It~n, VT USA 
B+~kg~+t~d: Fib~in~lyfi~ ~tpm prOteinS +n v¢'SS~t walt~ fntluenco vascular 
smooth mu~ c~i (~MC) migration ~ proliferation as wit| a+ Oxtr~el. 
lutar matrix (ECM) t,jm0v~r, Hyatu,,gnan (HA), a ~+~.ffated, golyanionlc 
glyc(~+amin¢~Jlycan i5 c0mpvi~rd of ~peal+mJ diSacchande units ar~ is a 
coml~n~nt Of ~CM in rtoiTnal Vessels that tnff~n(;e5 cell prolife~tion, lo- 
comotion, and migratKm rr~diated by the (:;ell s .da~ receptor CD44 Its 
concentration iS increased in the ttlniCa media el macroscopK;ally normal 
artenal waits, in vessels m p~ht~..~ wffh tlPe II diabetes tOM), 
Method.s: To d~tormin0 wh~thar HA altars expression of tibnnolyl]c system 
prote!ns by human vascular SMC.~ thereby potentially Cont~bufing to the 
evOluf~n of vascular dm~a~ in ~ II DM, human SMC in culture were 
exposed to selected concentrations el HA, Urokinase~type and flssue-typo 
plasminogen activatoos (uPA and tPA) and plasmi~en activator inhibitor-1 
(PAl.l), the pnmmy physiologic inhibitor of plasminogen actNators, were 
assayed in conditioned media (CM) and in cell lysates (CL) by ELISA and 
western blotting. 
Results: HA induced release of PAI+I into CM in a c~ncenfration-depen- 
dent and time-dependent manner (1.8-told over control w~th 1 mojml HA 
at 24 hr [n = 9, p < 0,01])+ uPA accumulation in C.,;+~ increased in an HA 
concentratlon-del:~ndent fashion. By contrast, uPA was reduced in CL (64% 
of control with 0.1 mg~ml HA at 24 hr [n = 9. p • 0+01]). The amounts of 
PAbl in CL and tPA in CM and CL were not changed. Either digestion of 
HA with hyalumnidase (50 TRU/ml, 4B hr, pH 4.2) or exposure at ft'~ cells tO 
anti+human CD44 antibody that binds to the HA cell surface receptor, CD44 
(1 ng/ml, 4'~:~, 1 hr), obmated the effects of HA on PAl-1 and uP/),+ More 
intense HA and hyalumnidase sensitive alcian blue staming signals were 
detected in atherectomy specimens from patients with type II DM (n = 10) 
compared w~th those from non-diabebc patients In = 3). Intense HA stammg 
was assoc0ated with increased CD--44 imunostatning el SMC. 
Conclusions: The results indicate that increased HA in walls ot vessels 
from Wpe II may alter elaboration of tibnnolytzc system components =n patients 
with DM and exacerbates evolution of the macroangtopathy seen =n type it 
DM by inhibiting pmteolytic aCtMty and plasmin<lependent ECM 0~gradation 
turnover. 
• Connective Growth Factor Inhibits Tissue 
Proliferation of Human Aortic Smooth Muscle 
Cells 
K. Hishtkawa, F.C, Tanner, B.S. Oemar, T.F Luscher. Cardiology, Unwersity 
Hospital z:Emch+ and Cardiova~ccular Research. InSlitute of PhysiologY. 
UniversRy of ZCJrich, Switzerland 
Background: Connective tissue growth factor (CTGF) is a novel cystetne+ 
rich, secreted immediate arly gone product which IS implicated in human 
atherosolerosis (Circulation 95:831, 1997)+ The present study is designed 
tO investigate the function of CTGF in human aortic smooth muscle ceils in 
vitro. 
Methods: Cultured human aortic smooth muscle cells were transiently 
transfected with an expression vector conta!ning the entire protein cod- 
ing sequence of the CTGF gene (~1,1 kb) 6riven by a CMV promoter 
[pCMV+CTGF). Cell proliferation was evaluated by ~H .thymidine uptake and 
cell number. The effect Of CTGF overexpmssion on cell proliferation was 
assesed in transfected cells stimulated with 5 ng/ml platelet cleaved growth 
factor (PDGF)-BB. 
Results: Overexpression of the 1,1 kb CTGF gene transcnpt in aortic 
smooth muscle cells could be dereonstmted 48 h after transfect(on by North- 
em analysis. Them was no significant differences in cell growth between 
mock transfectsd contacts and unstimu]ated CTGF*transfected ceils, How- 
ever, ceil proliferation was inhibited by 60-70% in CTGF-transfected ceils 
stimulated with PDGF as compared to mock transfected celts stimulated with 
PDGF or untransfected cells stimulated with PDGE 
Concfu~+on Our rocutf~ howod tf~t CTGI ~ i~ a potent growlh m~blfor for 
human aodtc smooth muscle coils in vitlO, CO~h'~++y to ~ pr~Ntou5 fin@ng In 
NIH.3T3 (:ells in which CTGF has been shown to Etlmulate v'~ pmt~fefat~,n 
(J Cell Biol 114: 1~85, 1~)11 The ~hani~m by wtl¢.h CTGI~ mo~btates 
vasctdar smooth mus~;le cell gro~,~h ~s ~nknown at that pre~flt lrt~ 
• Ohan(tn In camtae 8h=l~ In the h~l'mmlc 
Pofl:lne Heert Does NOt Contfll~lo to 
Improvement In MyO~Ifdllll Fim'~tton Follow~ 
Adenovlrui, l l t4Kl~ted ~ T1,MI~f~ of  (:DNA for 
V~m¢.lAf Endothelial G~Nth Fletor 
RJT. Hahn, C A. Mack, S.R Paf~l, A. Iler¢it, O. Fishm~n, fl+l~, Oev+r~, 
R.G. Costal. TK, Ro~n~art, Cumuli Med~:+t C~nt~r, ~ ~rk, N~ 1¢~, 
t~ackg.,o~nd: We have pr+~OUsh/~hewn fh+t direr myoc~rt~at in~r t  0f 
va+~-'~laf end~lhelial growth lacier ~fili~mQi a mplP.J~tf0rt-d~fokStlt a+in~s  
v~.;Io~ (A~vVEGF 10) +reprOveS l~th/he l~fuBten ~n~l wp+t~ hickening dur- 
ing sirass-induced my~rdlat i~ct~m~a +n l~ge+, Hewover #egm~tal d~tafa- 
lion may chan~;le wait Slm~S th~a affecting my~:a~mt fgrOtK~n without change 
Methods: Yorkshire swine had an ~mer~id constn~0r gla~;e~ on the c~r. 
cumflex coro~ adept at left tho~cotomy+ Thre~ wl~k=, fOlio+rag amerind, 
each animal received dim~ left ventncular (LV) injections 0f ~ther Ad~v 
VEGE10 In = 7) or control vector In = 8)+ Stress echo d~nng atrlal pacing 
was performed just pnor to veCtor inlC-~ion, and 4 wks foll(~ving vector. Wall 
lhicknes~s in the i sc~l~ and OppoSite Inon+isch~ffttfc) fe~ in l~'sl'..~ 
(WI"~) and diastole {WT]D) were me~,l~ured aed segr~nlal virtual ra~i r 
puled at peak stress. Circumferential er~.Systoli¢ wall sltes~ (tESS) w~.~ 
calculated from denved ";egmettfat intemal diameler~, w'r's and systo I , 6P 
Fractional wag tr.: ;honing (FV~ was the dilferance in WTS and WTP +',V~'~t 
by W~. 
Results: Tha difference m percent FWT between nomschem, .el m+ 
chemic regions wa~, significantly improved in AdGvVEGF,10 animms com. 
pared to controls (-0.6% ¢ 3.30% vs I~'+4% ~. 4.(]%, p ~ 003). Neither 
cESS nor segmental LV radius differed between the AdovVEGE10 and con. 
fml grOups, at either ~ pro-vector or postovector time po=n1~. 
Conclusions: Changes in walt stress and internal radius Of curvature do 
not contr+bute O the improvement in ca~Jiac function seen with adminlstr~tto~ 
ot AdGvVEGEt0, suggesting that changes m contra~illty I~r se domir~te 
the Improvement mmyocardial function. 
1~-1~ Effect of Oigaalis Gnycosides on Collateral 
Development in Ischemic Myocsrdium 
V Thirumurtl. M Shou, E.A. Hedge, L Goncalves, S.E Epsfe, n, EF Unger. 
Cardiot~. y Branch, NHLBL Bethesda MD. USA 
Background: Recent stuclies suggest that basic; fibreblast grewlh feeler 
(bFGF) is secreted by Cells though a r~chan=sm linked tO the Na+KoATPase 
pump. a process that is inhibited by digitalis glycosides uch as ouabain. We 
hypothesized that these compounds could potentiaTly mhibit he aogfogen¢ 
response mediated hy bFGF m ~ivo. ThK~ is a matter of clinical importance 
m light of the common use of digoxin in patients with ,schemic hear dis- 
ease. Thus. we sought to charecfenze the effect o! digoxin on the ¢ollsteml 
response to tschemi~ in dogs subjected to progressive coronary occltmon+ 
Methods: Mongrel dogs were randomized TO receive oral digexin (n = g) 
or no intervention (n = 8). One week after initiation of treatment, an amend 
constrictor was implanted on the proximal left circt~flex coronary artery+ 
Maximal collateral perfusi0n was assessed 10. 17, 24, 31 and 38 days 
attar amerotd placement Serum digoxtn levels were m~nfamed within the 
therapeutic range for the duration of treatment; reatment was disconlinued 
on day 24. 
Results: Collateral function, expressed as a ratio of ischemic/normal zone 
pedusion, was identical in digomn-tmated dogs and controls at the final time 
point, 0.39 ~ 0.03 v~ 038 ± 0.04, respectively. 
Conclusions: Dlgoxin therapy during progress=re coronary occlusion had 
no apparent effect on collateral development in this model, implying that the 
Na.K-ATPase pump does not play a significant role in myoca~ial angtogeno- 
sis. It is possible thai the release of stored t~FGF from the e~.lraceltular matnx 
or other growth factors are sufficient to modulate the angiogenic response =n 
this setting. 
